Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mechanisms of RSV and Air Pollution Interaction: A Scoping Review. | Int J Mol Sci | 2022 | 36293561 | PubTator, text mining | PubMed |
| miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs. | Int J Mol Sci | 2022 | 36293105 | PubTator, text mining | PubMed |
| IL17F Expression as an Early Sign of Oxidative Stress-Induced Cytotoxicity/Apoptosis. | Genes (Basel) | 2022 | 36292624 | PubTator, text mining | PubMed |
| Paracrine Senescence of Mesenchymal Stromal Cells Involves Inflammatory Cytokines and the NF-κB Pathway. | Cells | 2022 | 36291189 | PubTator, text mining | PubMed |
| Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents. | Antibiotics (Basel) | 2022 | 36290089 | PubTator, text mining | PubMed |
| Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth. | Biomedicines | 2022 | 36289670 | PubTator, text mining | PubMed |
| A methodology for classifying tissue-specific metabolic and inflammatory receptor functions applied to subcutaneous and visceral adipose. | PLoS One | 2022 | 36282842 | PubTator, text mining | PubMed |
| The incidence of opportunistic infections in patients with psoriatic arthritis treated with biologic and targeted synthetic agents: A systematic review and meta-analysis. | Front Pharmacol | 2022 | 36278224 | PubTator, text mining | PubMed |
| Adipose-Derived Stem Cell Exosomes Inhibit Hypertrophic Scaring Formation by Regulating Th17/Treg Cell Balance. | Biomed Res Int | 2022 | 36277890 | PubTator, text mining | PubMed |
| Airway smooth muscle function in asthma. | Front Physiol | 2022 | 36277199 | PubTator, text mining | PubMed |
| lncRNA IL-17RA-1 Attenuates LPS-Induced Sepsis via miR-7847-3p/PRKCG-Mediated MAPK Signaling Pathway. | Mediators Inflamm | 2022 | 36274974 | PubTator, text mining | PubMed |
| IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. | Nat Immunol | 2022 | 36271146 | PubTator, text mining | PubMed |
| CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology. | Nat Immunol | 2022 | 36271145 | PubTator, text mining | PubMed |
| Bioinformatics analysis of genomic and immune infiltration patterns in autism spectrum disorder. | Ann Transl Med | 2022 | 36267781 | PubTator, text mining | PubMed |
| The role of SARS-CoV-2 accessory proteins in immune evasion. | Biomed Pharmacother | 2022 | 36265309 | PubTator, text mining | PubMed |
| IL-17-induced dimerization of IL-17RA drives the formation of the IL-17 signalosome to potentiate signaling. | Cell Rep | 2022 | 36260993 | PubTator, text mining | PubMed |
| The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis. | PLoS One | 2022 | 36256663 | PubTator, text mining | PubMed |
| Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer. | Front Pharmacol | 2022 | 36249755 | PubTator, text mining | PubMed |
| Interleukin-17 as a potential therapeutic target for chronic pain. | Front Immunol | 2022 | 36248896 | PubTator, text mining | PubMed |
| Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM. | Front Immunol | 2022 | 36248827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=44